Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Trading Statement

12 Apr 2018 07:00

RNS Number : 6330K
Scapa Group PLC
12 April 2018
 

 

12 April 2018

 

Scapa Group plc ("Scapa" or "the Group")

 

Year-end trading update

 

Scapa Group plc (AIM: SCPA) is today providing an unaudited year end update for the twelve months ended 31 March 2018.  

 

The Group performed well and the good progress reported in the Interim Results has continued. Overall Group results are in line with the improved expectations outlined in the Group's October trading update.

Healthcare: Revenues grew 3.8% for the year, despite currency headwinds in H2. Sales growth in H2 was strong at 6.8% on a constant currency basis. Margins for the year are expected to be above 15% reflecting the investment in the integration of two technology transfers completed during the year.

Industrial: Industrial continues to deliver on its asset optimisation strategy. Industrial margin further improved driven by the benefit of Asian restructuring and more efficient cost to serve. The Markel acquisition is complete and site consolidations are underway.

Healthy cash flow in the period ensured the Group ended the year with net debt of £3.8m, after the acquisition of Markel Industries for US$10.2m (£7.6m) and BioMed Laboratories LLC for US$19m (£13.6m).

Heejae Chae, CEO commented:

"This year we have delivered another set of strong results, and completed two acquisitions: Markel, our first Industrial acquisition, and BioMed, our first Healthcare acquisition outside adhesive technology. We also completed two technology transfers in Healthcare as we execute our growth strategy. I believe there is clear potential, in both Healthcare and Industrial, to further improve performance through organic growth, efficiency and acquisitions.

It is with great sadness that we announced yesterday a fatal accident at the Dunstable facility in the UK. I join with all of my colleagues and fellow directors in expressing our sincere condolences to the family and friends of the deceased."

Scapa expects to report its full year results on 22 May 2018.

This announcement contains inside information.

For further information:

Scapa Group plc Heejae Chae - Chief Executive Tel: 0161 301 7430

Graham Hardcastle - Finance Director

 

Numis Securities Limited Mark Lander, Richard Thomas Tel: 020 7260 1000

(Nominated Adviser/Joint Broker)

 

Berenberg Chris Bowman Tel: 020 3207 7800

(Joint Broker)

 

Weber Shandwick Financial PR Nick Oborne Tel: 0207 067 0000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKDDPPBKDBQD
Date   Source Headline
19th May 20201:35 pmRNSStandard form for notification of major holdings
14th May 202012:06 pmRNSResults of Placing
14th May 20207:00 amRNSTrading Update, Financing and Proposed Placing
7th May 20207:00 amRNSUpdate on Notice of Full Year Results
4th May 20207:00 amRNSDirectorate Changes
30th Apr 202010:20 amRNSTotal Voting Rights
27th Apr 20203:03 pmRNSHolding(s) in Company
16th Apr 20209:33 amRNSAdditional Listing of Shares
31st Mar 202010:00 amRNSTotal Voting Rights
27th Mar 20207:00 amRNSCOVID-19 UPDATE
20th Mar 202012:07 pmRNSSecond Price Monitoring Extn
20th Mar 202012:02 pmRNSPrice Monitoring Extension
17th Mar 202010:00 amRNSBlock Listing Application
3rd Mar 202012:07 pmRNSSecond Price Monitoring Extn
3rd Mar 202012:02 pmRNSPrice Monitoring Extension
2nd Mar 20209:41 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSScapa Group Directorate Change
27th Feb 202011:44 amRNSHolding(s) in Company
14th Feb 20209:00 amRNSHolding(s) in Company
12th Feb 202010:00 amRNSHolding(s) in Company
12th Feb 20207:00 amRNSTrading Update
31st Jan 202010:15 amRNSTotal Voting Rights
24th Jan 202010:45 amRNSBlock listing six monthly return
20th Jan 20202:38 pmRNSDirectorate Appointment
2nd Jan 20202:06 pmRNSTotal Voting Rights
29th Nov 201911:08 amRNSTotal Voting Rights
28th Nov 20192:41 pmRNSStandard form for notification of major holdings
22nd Nov 20191:17 pmRNSCorrection - Holding(s) in Company
21st Nov 201910:14 amRNSHolding(s) in Company
19th Nov 20197:00 amRNSScapa Group: Interim Results
12th Nov 20194:16 pmRNSStandard form for notification of major holdings
31st Oct 20199:58 amRNSTotal Voting Rights
25th Oct 20197:00 amRNSNotice of Results
9th Oct 20197:00 amRNSPeriod end update
30th Sep 20199:20 amRNSTotal Voting Rights
13th Sep 201911:19 amRNSDirector/PDMR Shareholding
30th Aug 20199:22 amRNSTotal Voting Rights
7th Aug 20194:29 pmRNSAdditional Listing
31st Jul 20193:29 pmRNSTotal Voting Rights
25th Jul 201910:30 amRNSBlock listing Interim Review
23rd Jul 20194:39 pmRNSResult of AGM
23rd Jul 20197:00 amRNSAGM Statement
11th Jul 20197:00 amRNSScapa commences legal action against ConvaTec
9th Jul 201910:38 amRNSAdditional Listing
2nd Jul 20191:37 pmRNSTotal Voting Rights
28th Jun 20193:36 pmRNSDirectorate Change
21st Jun 20192:05 pmRNSDirector/PDMR Shareholding
19th Jun 201912:49 pmRNSHolding(s) in Company
18th Jun 20198:46 amRNSDirector/PDMR Shareholding
14th Jun 20199:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.